Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01423006 · ClinicalTrials.gov registry record · NA
Pilot Study on Focal Prostate Radio-Frequency Ablation
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01423006 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 5 participants.
The verdict
NCT01423006, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This is a prospective pilot study. The purpose of this research study is to evaluate the safety and efficacy of focal Radio-Frequency Ablation (RFA) in men with low-risk, clinically localized prostate cancer.
Interventions
- PROCEDURE Radio-Frequency Ablation (RFA) ENCAGE™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-08 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01423006
The ClinicalTrials.gov registry entry for NCT01423006 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radio-Frequency Ablation (RFA) ENCAGE™ is the first listed.
NCT01423006 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01423006 about?
NCT01423006 is a clinical study titled "Pilot Study on Focal Prostate Radio-Frequency Ablation". This is a prospective pilot study. The purpose of this research study is to evaluate the safety and efficacy of focal Radio-Frequency Ablation (RFA) in men with low-risk, clinically localized prostate cancer.
What is the current status of trial NCT01423006?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2011-08. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01423006?
The interventions under investigation include: Radio-Frequency Ablation (RFA) ENCAGE™ (PROCEDURE).
Who is sponsoring clinical trial NCT01423006?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.